The immune response and its therapeutic modulation in bronchiectasis

Pulmonary Medicine

Volumn , Issue , 2012, Pages

  Daheshia, Massoud ^a   Prahl, James D ^a   Carmichael, Jacob J ^a   Parrish, John S ^a   Seda, Gilbert ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CATHEPSIN B; CATHEPSIN G; CHEMOKINE RECEPTOR CXCR1; COLLAGENASE 3; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; HLA C ANTIGEN; HLA DR1 ANTIGEN; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; NITRIC OXIDE; SERUM AMYLOID A; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; BRONCHIECTASIS; CELL INFILTRATION; COLON RESECTION; ERYTHROCYTE SEDIMENTATION RATE; EXTRAVASATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NEUTROPHIL; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SPUTUM;

EID: 84876509609     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2012/280528     Document Type: Review

References (70)

1. King P. T., The pathophysiology of bronchiectasis. International Journal of Chronic Obstructive Pulmonary Disease 2009 4 411 419
2. Zheng L., Shum I. H., Tipoe G. L., Leung R., Lam W. K., Ooi G. C., Tsang K. W., Macrophages, neutrophils and tumour necrosis factor- α expression in bronchiectatic airways in vivo. Respiratory Medicine 2001 95 10 792 798 2-s2.0-0034764130 10.1053/rmed.2001.1155 (Pubitemid 33019573)
3. + T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998 53 8 685 691 2-s2.0-0031847529 (Pubitemid 28378485)
4. Sepper R., Konttinen Y. T., Kemppinen P., Sorsa T., Eklund K. K., Mast cells in bronchiectasis. Annals of Medicine 1998 30 3 307 315 2-s2.0-0031779895 (Pubitemid 28306457)
5. + T lymphocytes with FEV1. American Journal of Respiratory and Critical Care Medicine 1997 155 3 852 857 2-s2.0-0030900606 (Pubitemid 27133393)
6. Eller J., Lapae Silva J. R., Poulter L. W., Lode H., Cole P. J., Cells and cytokines in chronic bronchial infection. Annals of the New York Academy of Sciences 1994 725 331 345 2-s2.0-0028332306 10.1111/j.1749-6632.1994.tb39816.x (Pubitemid 24222062)
7. Lapa e Silva J. R., Guerreiro D., Noble B., Poulter L. W., Cole P. J., Immunopathology of experimental bronchiectasis. American Journal of Respiratory Cell and Molecular Biology 1989 1 4 297 304 2-s2.0-0024741090
8. Guran T., Ersu R., Karadag B., Karakoc F., Demirel G. Y., Hekim N., Dagli E., Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis. Journal of Clinical Pharmacy and Therapeutics 2008 33 6 603 611 2-s2.0-55949121601 10.1111/j.1365-2710.2008.00951.x
9. Angrill J., Agustí C., Torres A., Bronchiectasis. Current Opinion in Infectious Diseases 2001 14 2 193 197 2-s2.0-0035082408 (Pubitemid 32231106)
10. Guran T., Ersu R., Karadag B., Akpinar I. N., Demirel G. Y., Hekim N., Dagli E., Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis. Pediatric Pulmonology 2007 42 4 362 369 2-s2.0-34247238350 10.1002/ppul.20587 (Pubitemid 46608906)
11. Watt A. P., Brown V., Courtney J., Kelly M., Garske L., Elborn J. S., Ennis M., Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax 2004 59 3 231 236 2-s2.0-1542405167 10.1136/thx.2003. 008037 (Pubitemid 38339880)
12. Richman-Eisenstat J. B. Y., Jorens P. G., Hebert C. A., Ueki I., Nadel J. A., Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. American Journal of Physiology 1993 264 4 L413 L418 2-s2.0-0027251739 (Pubitemid 23125320)
13. Currie D. C., Pavia D., Lopez-Vidriero M. T., Impaired tracheobronchial clearance in bronchiectasis. Thorax 1987 42 2 126 130 2-s2.0-0023105825 (Pubitemid 17020314)
14. Chan S. C. H., Leung V. O. Y., Ip M. S. M., Shum D. K. Y., Shed syndecan-1 restricts neutrophil elastase from α 1-antitrypsin in neutrophilic airway inflammation. American Journal of Respiratory Cell and Molecular Biology 2009 41 5 620 628 2-s2.0-70450159308 10.1165/rcmb.2008-0185OC
15. Soini Y., Satta J., Mtt M., Autio-Harmainen H., In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. Journal of Pathology 2001 194 2 232 238 2-s2.0-0034993141 10.1002/path.849 (Pubitemid 32519973)
16. Shoemark A., Devaraj A., Meister M., Ozerovitch L., Hansell D. M., Wilson R., Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity. Respiratory Medicine 2011 105 6 885 891 2-s2.0-79955465970 10.1016/j.rmed.2011.01.015
17. 2 in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002 121 1 81 87 2-s2.0-0036152782 10.1378/chest.121.1.81 (Pubitemid 34114231)
18. Wilson C. B., Jones P. W., O'Leary C. J., Hansell D. M., Dowling R. B., Cole P. J., Wilson R., Systemic markers of inflammation in stable bronchiectasis. European Respiratory Journal 1998 12 4 820 824 2-s2.0-0031722626 10.1183/09031936.98.12040820 (Pubitemid 28491651)
19. Ip M., Lam W. K., Chan J. C., Liong E., Systemic effects of inflammation in bronchiectasis. Respiratory Medicine 1991 85 6 521 525 2-s2.0-0026047442
20. Murphy M. B., Reen D. J., Fitzgerald M. X., Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax 1984 39 3 179 184 2-s2.0-0021363491 (Pubitemid 14154223)
21. Martínez-García M. A., Soler-Catalua J. J., Perpiá-Tordera M., Román-Sánchez P., Soriano J., Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007 132 5 1565 1572 2-s2.0-36348949002 10.1378/chest.07-0490 (Pubitemid 350156014)
22. Mak J. C. W., Ho S. P., Leung R. Y. H., Ho P. L., Ooi C., Tipoe G. L., Yan C., Ip M. S. M., Lam W. K., Tsang K. W. T., Elevated levels of transforming growth factor- β 1 in serum of patients with stable bronchiectasis. Respiratory Medicine 2005 99 10 1223 1228 2-s2.0-24344442810 10.1016/j.rmed.2005.02.039 (Pubitemid 41245307)
23. Nel A. E., Strachan A. F., Welke H. E., de Beer F. C., Acute phase response in bronchiectasis and bronchus carcinoma. Respiration 1984 45 4 406 410 2-s2.0-0021180184 (Pubitemid 14089518)
24. Cano N. J., Pichard C., Roth H., Clinical Research Group of the Société Francophone de Nutrition Entérale et Parentérale. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 2004 126 540 546
25. Zheng L., Tipoe G., Lam W. K., Leung R. Y. H., Ho J. C., Shum I. H., Ooi G. C., Ip M. S., Tsang K. W., Up-regulation of circulating adhesion molecules in bronchiectasis. European Respiratory Journal 2000 16 4 691 696 2-s2.0-0033773010 10.1034/j.1399-3003.2000.16d21.x
26. Martínez-García M. Á., Perpiá-Tordera M., Román-Sánchez P., Soler-Catalua J. J., Carratalá A., Yago M., Pastor M. J., The association between bronchiectasis, systemic inflammation, and tumor necrosis factor α Archivos de Bronconeumologia 2008 44 1 8 14 2-s2.0-43449101843 10.1016/S1579-2129(08)60003-8 (Pubitemid 351670876)
27. Ergan Arsava B., Cöplü L., Does airway colonization cause systemic inflammation in bronchiectasis? Tuberk Toraks 2011 59 340 347
28. Stockley R. A., Bronchiectasis-new therapeutic approaches based on pathogenesis. Clinics in Chest Medicine 1987 8 3 481 494 2-s2.0-0023601033 (Pubitemid 18019573)
29. Lloberes P., Montserrat E., Montserrat J. M., Picado C., Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis. Thorax 1992 47 2 88 92 2-s2.0-0026515724
30. Shum D. K. Y., Chan S. C. H., Ip M. S. M., Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor- α in sputum of patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2000 162 5 1925 1931 2-s2.0-0033679026
31. Sepper R., Prikk K., Tervahartiala T., Konttinen Y. T., Maisi P., Lópes-Otín C., Sorsa T., Collagenase-2 and -3 are inhibited by doxycycline in the chronically inflamed lung in bronchiectasis. Annals of the New York Academy of Sciences 1999 878 683 685 2-s2.0-0032816214 10.1111/j.1749-6632.1999.tb07761.x (Pubitemid 29353647)
32. Goeminne P., Dupont L., Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgraduate Medical Journal 2010 86 1018 493 501 2-s2.0-77956034364 10.1136/pgmj.2009.091041
33. Fahy J. V., Schuster A., Ueki I., Boushey H. A., Nadel J. A., Mucus hypersecretion in bronchiectasis: the role of neutrophil proteases. American Review of Respiratory Disease 1992 146 6 1430 1433 2-s2.0-0026457499
34. Sykes D. A., Wilson R., Greenstone M., Deleterious effects of purulent sputum sol on human ciliary function in vitro: at least two factors identified. Thorax 1987 42 4 256 261 2-s2.0-0023092758 (Pubitemid 17058938)
35. Smallman L. A., Hill S. L., Stockley R. A., Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax 1984 39 9 663 667 2-s2.0-0021135892 (Pubitemid 14059514)
36. Stockley R. A., Bayley D., Hill S. L., Hill A. T., Crooks S., Campbell E. J., Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax 2001 56 5 366 372 2-s2.0-0035043191 10.1136/thorax.56.5. 366 (Pubitemid 32398127)
37. Stockley R. A., Hill S. L., Morrison H. M., Starkie C. M., Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax 1984 39 6 408 413 2-s2.0-0021270155 (Pubitemid 14107114)
38. Kim S., Nadel J. A., Role of neutrophils in mucus hypersecretion in COPD and implications for therapy. Treatments in Respiratory Medicine 2004 3 3 147 159 2-s2.0-3442889406 10.2165/00151829-200403030-00003 (Pubitemid 39004400)
39. Pasteur M. C., Helliwell S. M., Houghton S. J., Webb S. C., Foweraker J. E., Coulden R. A., Flower C. D., Bilton D., Keogan M. T., An investigation into causative factors in patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2000 162 4 I 1277 1284 2-s2.0-0033773862
40. Baydarian M., Walter R. N., Bronchiectasis: introduction, etiology, and clinical features. Disease-a-Month 2008 54 8 516 526 2-s2.0-47049105075 10.1016/j.disamonth.2008.05.007 (Pubitemid 351970093)
41. Metafratzi Z. M., Georgiadis A. N., Ioannidou C. V., Alamanos Y., Vassiliou M. P., Zikou A. K., Raptis G., Drosos A. A., Efremidis S. C., Pulmonary involvement in patients with early rheumatoid arthritis. Scandinavian Journal of Rheumatology 2007 36 5 338 344 2-s2.0-35648943308 10.1080/03009740701393957 (Pubitemid 350034803)
42. Boyton R. J., Altmann D. M., Asthma: new developments in cytokine regulation. Clinical and Experimental Immunology 2004 136 1 13 14 2-s2.0-1842560225 10.1111/j.1365-2249.2004.02452.x (Pubitemid 38437759)
43. Demoruelle M. K., Weisman M. H., Simonian P. L., Lynch D. A., Sachs P. B., Pedraza I. F., Harrington A. R., Kolfenbach J. R., Striebich C. C., Pham Q. N., Strickland C. D., Petersen B. D., Parish M. C., Derber L. A., Norris J. M., Holers V. M., Deane K. D., Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis and Rheumatism 2012 64 6 1756 1761 2-s2.0-84861801524 10.1002/art.34344
44. Popler J., Alimohammadi M., Kämpe O., Autoimmune polyendocrine syndrome type 1: utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatric Pulmonology 2012 47 84 87
45. Dunn A. C., Walmsley R. S., Dedrick R. L., Wakefield A. J., Lockwood C. M., Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/ permeability-increasing (BPI) protein recognize the carboxyl terminal domain. Journal of Infection 1999 39 1 81 87 2-s2.0-0032868809 10.1016/S0163-4453(99) 90107-X (Pubitemid 29396611)
46. Eaton T. E., Lambie N., Wells A. U., Bronchiectasis following colectomy for Crohn's disease. Thorax 1998 53 6 529 531 2-s2.0-0031780709 (Pubitemid 28308074)
47. Martínez García M. A., Máiz Carro L., Catalán Serra P., Treatment of non-cystic fibrosis bronchiectasis. Archivos de Bronconeumologia 2011 47 599 609 2-s2.0-79960659119 10.1016/j.arbres.2011.06.003
48. Boyton R. J., Reynolds C., Wahid F. N., Jones M. G., Ozerovitch L., Ahmad T., Chaudhry A., Jewell D. P., Kon O. M., Smith J., Rose M., Newman-Taylor A. J., Cole P., Wilson R., Altmann D. M., IFN γ and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 2006 68 4 325 330 2-s2.0-33749558416 10.1111/j.1399-0039.2006.00670.x (Pubitemid 44536207)
49. Boyton R. J., Smith J., Jones M., Reynolds C., Ozerovitch L., Chaudhry A., Wilson R., Rose M., Altmann D. M., Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clinical and Experimental Immunology 2008 152 1 95 101 2-s2.0-40449086705 10.1111/j.1365-2249.2008.03596.x (Pubitemid 351347548)
50. Boyton R. J., Smith J., Ward R., Jones M., Ozerovitch L., Wilson R., Rose M., Trowsdale J., Altmann D. M., HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. American Journal of Respiratory and Critical Care Medicine 2006 173 3 327 333 2-s2.0-32144440100 10.1164/rccm.200501-124OC (Pubitemid 43209088)
51. Graham S. M., HIV-related pulmonary disorders: practice issues. Annals of Tropical Paediatrics 2007 27 4 243 252 2-s2.0-36448943954 10.1179/ 146532807X245625 (Pubitemid 350167609)
52. Sheikh S., Madiraju K., Steiner P., Rao M., Bronchiectasis in pediatric AIDS. Chest 1997 112 5 1202 1207 2-s2.0-0030723527 (Pubitemid 27497849)
53. Gadola S. D., Moins-Teisserenc H. T., Trowsdale J., Gross W. L., Cerundolo V., TAP deficiency syndrome. Clinical and Experimental Immunology 2000 121 2 173 178 2-s2.0-0033838822 10.1046/j.1365-2249.2000.01264.x (Pubitemid 30659751)
54. Sugiyama Y., Maeda H., Okumura K., Takaku F., Progressive sinobronchiectasis associated with the 'bare lymphocyte syndrome' in an adult. Chest 1986 89 3 398 401 2-s2.0-0022646845 (Pubitemid 16126307)
55. Donato L., De la Salle H., Hanau D., Tongio M. M., Oswald M., Vandevenne A., Geisert J., Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. Journal of Pediatrics 1995 127 6 895 900 2-s2.0-0029591999 10.1016/S0022-3476(95)70024-2 (Pubitemid 26003281)
56. Tabatabaie P., Aghamohammadi A., Mamishi S., Isaeian A., Heidari G., Abdollahzade S., Pirouzi P., Rezaei N., Heidarnazhad H., Ghazi B. M., Yeganeh M., Cheraghi T., Abolhasani H., Saghafi S., Alizadeh H., Anaraki M. R., Evaluation of humoral immune function in patients with bronchiectasis. Iranian Journal of Allergy, Asthma and Immunology 2008 7 2 69 77 2-s2.0-48849115479
57. Notarangelo L. D., Plebani A., Mazzolari E., Soresina A., Bondioni M. P., Genetic causes of bronchiectasis: primary immune deficiencies and the lung. Respiration 2007 74 3 264 275 2-s2.0-34249718476 10.1159/000101784 (Pubitemid 46828134)
58. Pereira A. C., Kokron C. M., Romagnolo B. M. S., Yagi C. S. A., Saldiva P. H. N., Filho G. L., Negri E. M., Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis. Clinics 2009 64 12 1155 1160 2-s2.0-75649146562 10.1590/S1807-59322009001200004
59. Detková D., De Gracia J., Lopes-da-Silva S., Vendrell M., Alvarez A., Guarner L., Vidaller A., Rodrigo M. J., Caragol I., Espanol T., Hernández M., Common variable immunodeficiency: association between memory B cells and lung diseases. Chest 2007 131 6 1883 1889 2-s2.0-34250858053 10.1378/chest.06-2994 (Pubitemid 46981650)
60. Rivoisy C., Gérard L., Boutboul D., DEFI study group. Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. Journal of Clinical Immunology 2012 32 98 105
61. Hiramatsu M., Shiraishi Y., Nakajima Y., Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. The Annals of Thoracic Surgery 2012 93 245 250
62. Boddana P., Webb L. H., Unsworth J., Brealey M., Bingham C., Harper S. J., Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon? Clinical Transplantation 2011 25 3 417 419 2-s2.0-79955091853 10.1111/j.1399-0012.2010. 01255.x
63. Gennery A. R., Cant A. J., Spickett G. P., Walshaw D., Hunter S., Hasan A., Hamilton J. R. L., Dark J., Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen. The Lancet 1998 351 9118 1778 1781 2-s2.0-0032513937 10.1016/S0140-6736(97)08486-9 (Pubitemid 28269189)
64. Steinfort D., Finlay M., Irving L., Diagnosis of peripheral pulmonary carcinoid tumor using endobronchial ultrasound. Annals of Thoracic Medicine 2008 3 4 146 148 2-s2.0-53649103849 10.4103/1817-1737.43082
65. Einsiedel L., Fernandes L., Spelman T., Steinfort D., Gotuzzo E., Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clinical Infectious Diseases 2012 54 43 50
66. Sugisaki K., Tsuda T., Kumamoto T., Akizuki S., Clinicopathologic characteristics of the lungs of patients with human T cell lymphotropic virus type 1-associated myelopathy. American Journal of Tropical Medicine and Hygiene 1998 58 6 721 725 2-s2.0-0031748701 (Pubitemid 28307387)
67. Barker A. F., Bronchiectasis. The New England Journal of Medicine 2002 346 18 1383 1393 2-s2.0-0037007684 10.1056/NEJMra012519 (Pubitemid 34754612)
68. Weycker D., Edelsberg J., Elizabeth Halloran M., Longini I. M., Nizam A., Ciuryla V., Oster G., Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005 23 10 1284 1293 2-s2.0-12344336431 10.1016/j.vaccine.2004.08.044 (Pubitemid 40126532)
69. Kapur N., Bell S., Kolbe J., Chang A. B., Inhaled steroids for bronchiectasis. Cochrane Database of Systematic Reviews 2009 21 1 2-s2.0-70249110381 10.1002/14651858.CD000996.pub2 CD000996
70. Geri G., Dadoun S., Bui T., Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infectious Diseases 2011 11 304 311